XSHE
300018
Market cap873mUSD
Oct 09, Last price
12.25CNY
1D
2.42%
1Q
-9.33%
Jan 2017
3.99%
IPO
43.95%
Name
Wuhan Zhongyuan Huadian Science & Technology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Wuhan, China, Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. operates extensively across the smart grid and healthcare industries within the nation. Its core capabilities in the smart grid arena encompass the full lifecycle of product development, from research and design to manufacturing, sales, and ongoing support. This includes sophisticated systems for intelligent recording and analytical processing of power data, precise time synchronization, holistic substation automation, and advanced distribution network automation. The firm's diverse product range features power fault recording apparatus, time synchronization units, integrated substation automation equipment, intelligent distribution network devices, and a variety of smart grid diagnostic tools. Additionally, the company is active in the healthcare sphere, providing medical informatization solutions and specialized in-vitro diagnostic products. Wuhan Zhongyuan Huadian Science & Technology Co.,Ltd. was founded in 2001.
Key people
Weibing Huang
Chief Financial Officer · since 2025
Na Kang
Vice President, Secretary of the Board · since 2025
Jinmei Xiong
Vice President · since 2016
Junlin Zheng
Chief Engineer · since 2023
Chunming Lu
President, Vice Chairman of the Board · since 2025
Mo Chen
Staff Elected Director · since 2025
Zhigang Deng
Director · since 2020
Director · since 2025
liguang Yin
Director · since 2025
Jian Yin
Chairman of the Board · since 2023
Dongsheng Jiang
Independent Director · since 2023
Dexian Yang
Independent Director · since 2023
Minggui Yu
Independent Director · since 2025
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||